Rx · PZN 17620250, 16679011
BORTEZOMIB Accord 3,5 mg powder for preparation of a solution for injection vial
German trade nameBORTEZOMIB Accord 3,5 mg Pulver zur Herstellung einer Injektionslösung Durchstechflasche
According to the data available to us: no longer marketed
No observed availability
0.0out of 10
Average purchase price (B2B)
We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.
This figure is an approximation across all recorded pack sizes. We are happy to advise you on your terms for BORTEZOMIB Accord 3,5 mg powder for preparation of a solution for injection vial.
Review purchasing termsBORTEZOMIB Accord 3,5 mg powder for preparation of a solution for injection vial contains the active ingredient Bortezomib. 2 pack sizes of this product are recorded. All packs reach a pharma availability index of 0.0 out of 10 over the past 30 days. According to our records, none of the recorded packs is currently marketed on a regular basis – sources of supply can be checked on request.
Pack sizes · 2 PZN
| PZN | Index 7 d | Index 30 d | Highest known purchase price |
|---|---|---|---|
| 17620250 | 0.0 | 0.0 | ~ €189 |
| 16679011 | 0.0 | 0.0 | ~ €1,101 |
According to the data available to us, BORTEZOMIB Accord 3,5 mg powder for preparation of a solution for injection vial is no longer regularly marketed. We help you identify successor products, remaining stock and import routes.
Request a source of supply